Health2Sync
PrivateLast Round
public_listing
Nov 19, 2025
Est. Valuation
$80M
Total Funding Raised
$29M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Health2Sync operates in Healthcare & Life Sciences and is based in Taipei. Its latest recorded funding round was a Series C round in March 2025.
Health2Sync is a digital health company that provides a mobile application and cloud-based platform for chronic disease management, particularly diabetes.
Sector
Healthcare & Life Sciences
Verticals
Patient Engagement, Medical Devices, Health IoT, Telemedicine, InsurTech
Business Model
B2B2C
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Health2Sync Comparables
Compare Health2Sync with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TruDoc Healthcare | 79% | |
| Glooko | 78% | |
| Doctor Diary | 78% |
For institutional investors. Book with your work email.
Health2Sync Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| public_listing | Nov 19, 2025 | ||||
| Series C | Mar 5, 2025 | ||||
| Series B | Dec 6, 2017 | ||||
| Series A | Aug 30, 2016 |
For institutional investors. Book with your work email.
Health2Sync Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cherubic Ventures | Series A, Seed |
| Taiwania Capital | Series C |
| WI Harper Group | Series B, Series A |
| Cathay Venture | Series C |
| ABIES Capital | Series C |
| A. Capital Ventures | Series B |
| iSeed Ventures | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2026
Open roles increased to 71, 2.3x the trailing average.
- Jul 20, 2026
Open roles increased to 47, 98% of headcount.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- integrates_withSep 13, 2026
Health2Sync integrates Biocorp's Mallya cap with its mobile diabetes management app, automatically sending insulin dosage, date and time data to the app in real time; the integration is available to about 350,000 users in Japan.
For institutional investors. Book with your work email.
Health2Sync Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Health2Sync's valuation, stock price, and market status.
Is Health2Sync a public or private company?
Health2Sync is a private company.
What is the current stock price of Health2Sync?
Health2Sync is a private company, so its shares have no public market price. Caplight tracks Health2Sync's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Health2Sync worth (valuation)?
Health2Sync's valuation is estimated at $80.0M based on funding round data.
Can I buy Health2Sync stock?
Health2Sync shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Health2Sync's last funding round?
Health2Sync's most recent funding round was public_listing on November 19, 2025.
Who are the main investors in Health2Sync?
Key investors in Health2Sync include Taiwania Capital, WI Harper Group.
Will Health2Sync IPO soon?
No public IPO plans have been announced for Health2Sync.
How can I track Health2Sync secondary market activity?
Caplight tracks bids, offers, and trades in Health2Sync's shares on secondary markets.